Baird Capital said Thursday that Michael Bernstein has rejoined the firm as a partner in its U.S. private equity group. Based in Chicago, Bernstein first joined Baird Capital in 2008 as an executive-in-residence. He is also the former president and CEO of Medical Education Technologies, a portfolio company of Baird Capital.
CHICAGO, June 5, 2014 – Baird Capital, the direct private investment arm of Robert W. Baird & Co. (Baird), today announced that Michael Bernstein has rejoined the firm and will be a Partner in its U.S. Private Equity group. Based in Chicago, Bernstein will focus on investment opportunities in the healthcare sector.
Bernstein has nearly 30 years of operational and investment experience in the healthcare industry, including several executive management roles. Bernstein first joined Baird Capital in 2008 as an Executive-in-Residence, and was soon appointed President and CEO of Baird Capital portfolio company Medical Education Technologies, Inc. (METI). During his time at METI, Bernstein helped improve business performance and negotiated the sale of the company to CAE, a global leader in simulated education services. He then became President of CAE Healthcare, where he led the integration of METI, restructured the business and drove efficiency initiatives to improve profitability.
“We are very pleased to welcome Mike back to our team,” said Gordon Pan, Managing Partner of Baird Capital. “His proven ability to drive value in the companies he works with makes him an excellent addition to our healthcare platform.”
Bernstein’s prior executive experience includes serving as CEO of Leprechaun Inc., an outsource data management business focused on Risk Adjustment data mining for Medicare HMOs. He also previously served as President and CEO of Innovative Health Strategies, President and COO of the former Cobalt Corporation and Executive Vice President of the University of Wisconsin Medical Foundation.
“Baird Capital’s healthcare platform benefits from a strong global network of experts,” said Bernstein. “I am excited to be back with Baird Capital in this new role and look forward to working with the healthcare team to identify the best investment opportunities for our portfolio.”
About Baird Capital
Baird Capital makes venture capital, growth equity and private equity investments in strategically targeted sectors around the world. Since 1989, Baird Capital’s U.S. Private Equity group has invested in growing and profitable lower-middle-market companies in the Business Services, Healthcare, and Industrial and Consumer Products sectors. Having invested in more than 270 companies over its history, Baird Capital partners with entrepreneurs and, leveraging its executive networks, strives to build exceptional companies. Baird Capital provides operational support to its portfolio companies through teams on the ground in Asia, a proactive portfolio operations team and a deep network of relationships which together strive to deliver enhanced shareholder value. Baird Capital is the direct private investment arm of Robert W. Baird & Co. For more information, please visit BairdCapital.com.
Take your pick!
- Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
- VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.